Tolbutamide hydroxylation by human liver microsomes
Authors:
- Kerry J. SmithKSKerry J. Smith
- Richard A. RobsonRRRichard A. Robson
- Michael E. McManusMMMichael E. McManus
- Maurice E. VeroneseMVMaurice E. Veronese
- Donald J. BirkettDBDonald J. Birkett
- 1 March 1988
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 37 (6) , 1137-1144
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Characterisation of theophylline metabolism in human liver microsomes.British Journal of Clinical Pharmacology, 1987
- Selectivity and dose‐dependency of the inhibitory effect of propranolol on theophylline metabolism in man.British Journal of Clinical Pharmacology, 1985
- NORMAL METABOLISM OF DEBRISOQUINE AND THEOPHYLLINE IN A SLOW TOLBUTAMIDE METABOLISERAustralian and New Zealand Journal of Medicine, 1985
- Failure of ‘therapeutic’ doses of beta‐adrenoceptor antagonists to alter the disposition of tolbutamide and lignocaine.British Journal of Clinical Pharmacology, 1984
- Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline‐sulphinpyrazone interaction.British Journal of Clinical Pharmacology, 1983
- Cigarette smoking and theophyiiine clearance and metabolismClinical Pharmacology & Therapeutics, 1981
- Pharmacogenetics of tolbutamide metabolism in humansDiabetes, 1979
- Mechanisms of inhibition of tolbutamide metabolism: Phenylbutazone, oxyphenbutazone, sulfaphenazoleClinical Pharmacology & Therapeutics, 1977
- The Metabolic Fate of Tolbutamide in Man and in the RatJournal of Medicinal Chemistry, 1966
- The determination of enzyme inhibitor constantsBiochemical Journal, 1953